Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enfusion (ENFN)
NYSE:ENFN
Holding ENFN?
Track your performance easily
ENFN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.52 - $11.38
Previous Close$10.63
Volume935.39K
Average Volume (3M)419.62K
Market Cap
$1.35B
Enterprise Value$1.35B
Total Cash (Recent Filing)$48.30M
Total Debt (Recent Filing)$21.13M
Price to Earnings (P/E)405.7
Beta0.63
Next Earnings
Mar 20, 2025EPS Estimate
$0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding128,570,838
10 Day Avg. Volume790,460
30 Day Avg. Volume419,620
Standard Deviation0.16
R-Squared0.09
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)19.68
Price to Sales (P/S)6.90
Price to Cash Flow (P/CF)20.80
P/FCF Ratio22.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.89
Enterprise Value/Gross Profit11.51
Enterprise Value/Ebitda42.16
Forecast
1Y Price Target
$12.00Price Target Upside12.89% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Enfusion News
PremiumCompany Announcements
Enfusion, Inc. Reports Strong Q3 2024 Results
Bulls Say, Bears Say
Bulls Say
Client AcquisitionThe company won 38 new clients in 3Q24, bringing total customer growth and demonstrating strong client acquisition capabilities.
Growth And ProfitabilityEnfusion is well positioned to offer a solid balance of healthy growth and profitability, as it captures more traditional asset managers and larger clients through its expanded platform.
Strategic AlternativesAnalysts are constructive on the company's exploration of strategic alternatives and believe it could help attract incremental shareholders.
Bears Say
Economic UncertaintyBroader macro uncertainty presents a cautious outlook for the company's future opportunities.
Growth ChallengesBack-book growth is subdued due to lower net organic growth in Asia and domestic hedge fund clients.
Revenue GrowthA more measured pace of revenue growth acceleration is expected, with a revision to +18.5% growth.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ENFN FAQ
What was Enfusion’s price range in the past 12 months?
Enfusion lowest stock price was $7.52 and its highest was $11.38 in the past 12 months.
What is Enfusion’s market cap?
Currently, no data Available
When is Enfusion’s upcoming earnings report date?
Enfusion’s upcoming earnings report date is Mar 20, 2025 which is in 88 days.
How were Enfusion’s earnings last quarter?
Enfusion released its earnings results on Nov 04, 2024. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.057 by -$0.007.
Is Enfusion overvalued?
According to Wall Street analysts Enfusion’s price is currently Undervalued.
Does Enfusion pay dividends?
Enfusion does not currently pay dividends.
What is Enfusion’s EPS estimate?
Enfusion’s EPS estimate is $0.06.
How many shares outstanding does Enfusion have?
Enfusion has 94,372,070 shares outstanding.
What happened to Enfusion’s price movement after its last earnings report?
Enfusion reported an EPS of $0.05 in its last earnings report, missing expectations of $0.057. Following the earnings report the stock price went down -3.646%.
Which hedge fund is a major shareholder of Enfusion?
Among the largest hedge funds holding Enfusion’s share is Royce & Associates LLC. It holds Enfusion’s shares valued at 946K.
---
Enfusion Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.00 (12.89% Upside)
$12.00 (12.89% Upside)
Blogger Sentiment
Bullish
ENFN Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 17.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $680.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.15%
12-Months-Change
Fundamentals
Return on Equity
5.54%
Trailing 12-Months
Asset Growth
32.63%
Trailing 12-Months
Company Description
Enfusion
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute better-informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth.
---
ENFN Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with significant revenue and client growth, driven by strategic expansions and product innovations. However, challenges remain in the APAC region and with back book growth. The company's overall outlook remains positive, supported by strong market presence and innovative product developments.Read More>---
ENFN Stock 12 Month Forecast
Average Price Target
$12.00
▲(12.89% Upside)
Technical Analysis
Best Analysts Covering ENFN
1 Year
1 Year Success Rate
8/14 ratings generated profit
1 Year Average Return
-0.78%
reiterated a buy rating 2 months ago
Copying Dylan Becker's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of -0.78% per trade.
---